Technical Analysis for PRQR - ProQR Therapeutics B.V.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 6.57% | |
| Inside Day | Range Contraction | 6.57% | |
| Wide Bands | Range Expansion | 6.57% | |
| Wide Bands | Range Expansion | 1.91% | |
| Wide Bands | Range Expansion | 8.12% | |
| Gapped Up | Strength | 8.12% | |
| Wide Bands | Range Expansion | 12.69% | |
| Boomer Buy Setup | Bullish Swing Setup | 7.80% | |
| Calm After Storm | Range Contraction | 7.80% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 23 hours ago |
| Up 3% | about 23 hours ago |
| Rose Above 10 DMA | 1 day ago |
| Down 1% | 1 day ago |
| Up 2% | 1 day ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/01/2024
ProQR Therapeutics B.V., a biopharmaceutical company, is engaged in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. Its lead product candidate includes QR-010, a RNA-based oligonucleotide for the treatment of cystic fibrosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cystic Fibrosis Oligonucleotide Regulus Therapeutics Alnylam Pharmaceuticals Therapeutic Gene Modulation Genetic Disorder Treatment Of Cystic Fibrosis
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.62 |
| 52 Week Low | 1.185 |
| Average Volume | 1,567,893 |
| 200-Day Moving Average | 2.08 |
| 50-Day Moving Average | 2.36 |
| 20-Day Moving Average | 3.09 |
| 10-Day Moving Average | 3.59 |
| Average True Range | 0.36 |
| RSI (14) | 64.91 |
| ADX | 38.8 |
| +DI | 32.34 |
| -DI | 14.58 |
| Chandelier Exit (Long, 3 ATRs) | 3.54 |
| Chandelier Exit (Short, 3 ATRs) | 2.85 |
| Upper Bollinger Bands | 4.98 |
| Lower Bollinger Band | 1.20 |
| Percent B (%b) | 0.67 |
| BandWidth | 122.28 |
| MACD Line | 0.42 |
| MACD Signal Line | 0.42 |
| MACD Histogram | -0.0046 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.18 | ||||
| Resistance 3 (R3) | 4.14 | 3.94 | 4.11 | ||
| Resistance 2 (R2) | 3.94 | 3.83 | 3.97 | 4.08 | |
| Resistance 1 (R1) | 3.84 | 3.76 | 3.89 | 3.88 | 4.05 |
| Pivot Point | 3.64 | 3.64 | 3.67 | 3.67 | 3.64 |
| Support 1 (S1) | 3.54 | 3.53 | 3.59 | 3.58 | 3.41 |
| Support 2 (S2) | 3.34 | 3.46 | 3.37 | 3.38 | |
| Support 3 (S3) | 3.24 | 3.34 | 3.36 | ||
| Support 4 (S4) | 3.28 |
